Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis.

Monoclonal antibody Proprotein Convertase Subtilisin/Kexin type 9 (PCSK9) inhibitors reduce total cholesterol (TC), low density lipoproteins (LDL), high density lipoproteins (HDL), and triglycerides (TG). We assessed the ability of berberine, a natural PCSK9 inhibitor, to reduce lipid concentrations...

Full description

Bibliographic Details

Published in:	Journal of Dietary Supplements Vol. 21; no. 2; pp. 242 - 260
Main Authors:	Hernandez, Adrian V., Hwang, Jennifer, Nasreen, Iram, Sicignano, Dakota, Pasupuleti, Vinay, Snow-Caroti, Kimberly, White, C. Michael
Format:	meta analysis research systematic review tables/charts Journal Article
Published:	Taylor & Francis Ltd 2024
Online Access:	View this record in EBSCOhost